Trial | Studied treatment | Control treatment | patients | ROB | Result | NCT |
---|
|
|
CLIPS, 2007 | aspirin | placebo | | Low risk of bias | Suggesting | |
|
|
APIC, 1989 | acenocoumarol | placebo | | | - | |
|
Munich B, 1975 | aspirin | placebo | | | - | |
Munich A, 1975 | aspirin | placebo | | | - | |
Schoop, 1983 | aspirin | placebo | | | - | |
Hess, 1985 | aspirin | placebo | | | - | |
Lassila R, 1991 | aspirin | contrôle | | | - | |
BOA, 2000 | aspirin | | | | - | |
|
CAPRIE (PAD subgroup), 1996 | clopidogrel | aspirin | | | Suggesting | |
AFFIRM ongoing | clopidogrel | | | | - | |
|
Schoop (2), 1983 | aspirin + dipyridamol | placebo | | | - | |
Hess (2), 1985 | aspirin + dipyridamol | placebo | | | - | |
VA study, 1986 | aspirin + dipyridamol | placebo | | | - | |
|
Thulesius, 1987 | ketanserine | placebo | | | - | |
Walden, 1991 | ketanserine | placebo | | | - | |
PACK, 1996 | ketanserine | placebo | | | - | |
|
Coto, 1989 | picotamide | placebo | | | - | |
ADEP, 1993 | picotamide | placebo | | | - | |
Neirotti, 1994 | picotamide | placebo | | | - | |
|
Adriaensen, 1976 | suloctidil | placebo | | | - | |
Verhaeghe, 1981 | suloctidil | placebo | | | - | |
Jones, 1982 | suloctidil | placebo | | | - | |
Holm, 1984 | suloctidil | placebo | | | - | |
|
Hurlow, 1980 | ticlopidine | placebo | | | - | |
Krause, 1980 | ticlopidine | placebo | | | - | |
Katsumara, 1982 | ticlopidine | placebo | | | - | |
Aukland, 1982 | ticlopidine | placebo | | | - | |
Stiegler, 1984 | ticlopidine | placebo | | | - | |
Cloarec, 1986 | ticlopidine | placebo | | | - | |
Ellis, 1986 | ticlopidine | placebo | | | - | |
Arcan, 1988 | ticlopidine | placebo | | | - | |
Balsano, 1989 | ticlopidine | placebo | | | - | |
STIMS, 1990 | ticlopidine | placebo | | | - | |
EMATAP, 1993 | ticlopidine | placebo | | | - | |
Becquemin, 1997 | ticlopidine | contrôle | | | - | |
|
Tesi, 1989 | HNF | placebo | | | - | |
Antonicelli, 1999 | HNF | placebo | | | - | |
|
CRAMPS, 2000 | cloricromene | placebo | | | - | |
|
Sarac, 1998 | warfarin | contrôle | | | - | |
Johnson, 2002 | warfarin | contrôle | | | - | |
|
|
Mohler III, 2003 | atorvastatin | placebo | Peripheral Arterial Disease | Exploratory | - | |
|
LEADER trial, 2000 | bezafibrate | placebo | Peripheral Arterial Disease | Low risk of bias | - | |
|
CLAS, 1987 | colestipol-niacin | placebo | Peripheral Arterial Disease | Exploratory | - | |
|
PQRST, 1994 | probucol | placebo | Peripheral Arterial Disease | Exploratory | - | |
|
HPS (sub group), 2002 | simvastatin | placebo | Peripheral Arterial Disease | Low risk of bias | - | |
Mondillo, 2003 | simvastatin | placebo | Peripheral Arterial Disease | Exploratory | - | |
Aronow , 2003 | simvastatin | placebo | Peripheral Arterial Disease | Exploratory | - | |
|
|
Larsen OA, 1966 | Exercise Therapy | Control | | | - | |
Holm J, 1973 | Exercise Therapy | Control | | | - | |
Dahllof AG, 1974 | Exercise Therapy | Control | | | - | |
Hiatt WR, 1990 | Exercise Therapy | Control | | | - | |
Mannarino E, 1991 | Exercise Therapy | Control | | | - | |
Hiatt WR, 1994 | Exercise Therapy | Control | | | - | |
Tisi PV, 1997 | Exercise Therapy | Control | | | - | |
Gelin, 2001 | Exercise Therapy | Control | | | - | |
Gardner, 2001 | Exercise Therapy | Control | | | - | |
Fowler, 2002 | Exercise Therapy | Control | | | - | |
Lear PA ongoing | Exercise Therapy | Control | | | - | |
Pockley G ongoing | Exercise Therapy | Control | | | - | |
Stewart A ongoing | Exercise Therapy | Control | | | - | |
McCloskey B ongoing | Exercise Therapy | Control | | | - | |
Jayatunga AP ongoing | Exercise Therapy | Control | | | - | |
|
|
Diamantopoulos, 2001 | buflomédil | placebo | | | - | |
LIMB, 2008 | buflomedil | placebo | | Low risk of bias | Suggesting | |
|
Otsuka 21-95-201 | cilostazol | placebo | | | - | |
Dawson, 1998 | cilostazol | placebo | | | - | |
Money, 1998 | cilostazol | placebo | | | - | |
Elam, 1998 | cilostazol | placebo | | | - | |
Beebe, 1999 | cilostazol | placebo | | | - | |
Dawson (cilostazol), 2000 | cilostazol | placebo | | | - | |
Strandness, 2002 | cilostazol | placebo | | | - | |
|
Bauer, 1984 | ginko biloba | placebo | | | - | |
Peters, 1998 | ginko biloba | placebo | | | - | |
|
Clyne, 1980 | naftidrofuryl | placebo | | | - | |
Meehan, 1982 | naftidrofuryl IV | control | | | - | |
Negus, 1987 | naftidrofuryl IV | prostacyclin | | | - | |
Testart, 1994 | naftidrofuryl IV | placebo | | | - | |
NIQOL germany, 1999 | Naftidrofuryl | placebo | | | - | |
NIQOL belgium, 2001 | naftidrofuryl | placebo | | | - | |
NCIS, 2001 | naftidrofuryl | placebo | | | - | |
D'Hooge D, 2001 | naftidrofuryl IV | placebo | | | - | |
|
Porter, 1982 | pentoxifylline | placebo | | | - | |
Donaldson, 1984 | pentoxifylline | placebo | | | - | |
APIC, 1989 | pentoxifylline | placebo | | | - | |
Dawson (pentoxifylline), 2000 | pentoxifylline | placebo | | | - | |
Belcaro, 2002 | pentoxifylline | placebo | | | - | |